PURPOSE: Mammographic breast and bone mineral densities (BMD) have been associated with luteal phase hormone concentrations in premenopausal women. We assessed the associations of breast and bone densities with follicular phase hormones and sex hormone binding globulin (SHBG) in premenopausal women, given that follicular phase hormones have been shown to be positively associated with premenopausal breast cancer risk. METHODS: One hundred and ninety-two 40-45-year-old women provided a spot urine and/or blood sample during the follicular phase. Hormone and SHBG concentrations, and bone density were measured and routine mammograms were accessed and digitized to obtain breast density measures. Regression models were fit to assess the associations between hormones and SHBG, and breast and bone densities. RESULTS: Positive associations were observed between percent breast density and SHBG (p trend = 0.02), as well as estradiol (p trend = 0.08), after controlling for body mass index (BMI), number of pregnancies, and breast feeding history. In addition, a statistically significant inverse association was observed between total testosterone and head BMD (p trend = 0.01), after controlling for BMI. CONCLUSIONS: Associations were observed between breast and bone densities, and serum hormone concentrations during the follicular phase of the menstrual cycle.
PURPOSE: Mammographic breast and bone mineral densities (BMD) have been associated with luteal phase hormone concentrations in premenopausal women. We assessed the associations of breast and bone densities with follicular phase hormones and sex hormone binding globulin (SHBG) in premenopausal women, given that follicular phase hormones have been shown to be positively associated with premenopausal breast cancer risk. METHODS: One hundred and ninety-two 40-45-year-old women provided a spot urine and/or blood sample during the follicular phase. Hormone and SHBG concentrations, and bone density were measured and routine mammograms were accessed and digitized to obtain breast density measures. Regression models were fit to assess the associations between hormones and SHBG, and breast and bone densities. RESULTS: Positive associations were observed between percent breast density and SHBG (p trend = 0.02), as well as estradiol (p trend = 0.08), after controlling for body mass index (BMI), number of pregnancies, and breast feeding history. In addition, a statistically significant inverse association was observed between total testosterone and head BMD (p trend = 0.01), after controlling for BMI. CONCLUSIONS: Associations were observed between breast and bone densities, and serum hormone concentrations during the follicular phase of the menstrual cycle.
Authors: E Riza; I dos Santos Silva; B De Stavola; H L Bradlow; D W Sepkovic; D Linos; A Linos Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-06 Impact factor: 4.254
Authors: P Muti; H L Bradlow; A Micheli; V Krogh; J L Freudenheim; H J Schünemann; M Stanulla; J Yang; D W Sepkovic; M Trevisan; F Berrino Journal: Epidemiology Date: 2000-11 Impact factor: 4.822
Authors: R Leelawattana; K Ziambaras; J Roodman-Weiss; C Lyss; D Wagner; T Klug; R Armamento-Villareal; R Civitelli Journal: J Bone Miner Res Date: 2000-12 Impact factor: 6.741
Authors: Seungyoun Jung; Frank Z Stanczyk; Brian L Egleston; Linda G Snetselaar; Victor J Stevens; John A Shepherd; Linda Van Horn; Erin S LeBlanc; Kenneth Paris; Catherine Klifa; Joanne F Dorgan Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-11-04 Impact factor: 4.254
Authors: Karen C Schliep; Enrique F Schisterman; Sunni L Mumford; Anna Z Pollack; Cuilin Zhang; Aijun Ye; Joseph B Stanford; Ahmad O Hammoud; Christina A Porucznik; Jean Wactawski-Wende Journal: Am J Clin Nutr Date: 2012-01-11 Impact factor: 7.045
Authors: Scott V Adams; Polly A Newcomb; Martin M Shafer; Charlotte Atkinson; Erin J Aiello Bowles; Katherine M Newton; Johanna W Lampe Journal: Breast Cancer Res Treat Date: 2011-02-15 Impact factor: 4.872
Authors: Kimberly A Bertrand; A Heather Eliassen; Susan E Hankinson; Bernard A Rosner; Rulla M Tamimi Journal: Horm Cancer Date: 2018-01-12 Impact factor: 3.869
Authors: Karen J Wernli; Ellen S O'Meara; Karla Kerlikowske; Diana L Miglioretti; Carolyn Y Muller; Tracy Onega; Brian L Sprague; Louise M Henderson; Diana S M Buist Journal: J Natl Cancer Inst Date: 2013-12-05 Impact factor: 13.506